Resistome-based surveillance identifies ESKAPE pathogens as the predominant gram-negative organisms circulating in veterinary hospitals.
ESKAPE
companion animals
gram-negative
infection control
intensive care unit (ICU)
surveillance
veterinary
veterinary hospitals
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2023
2023
Historique:
received:
03
07
2023
accepted:
31
07
2023
medline:
25
9
2023
pubmed:
25
9
2023
entrez:
25
9
2023
Statut:
epublish
Résumé
Healthcare-associated infections (HCAIs) associated with extended-spectrum cephalosporin-resistant gram-negative (ESC-R GN) bacteria are an emerging concern in veterinary hospitals, especially in companion animal intensive care units (ICUs). To understand the molecular epidemiology of ESC-R GN isolates in two veterinary hospitals (equine and small animal), a 6-month pilot study was performed during which fecal and environmental samples were obtained twice from selected patients, upon ICU admission and after 48 h of hospitalization. In total, 295 ESC-R GNs were analyzed using the Acuitas Resistome ESKAPE GN pathogens were the most prevalent ESC-R GN isolates circulating in both the small animal and equine hospitals, consisting of We describe the widespread occurrence of ESKAPE gram-negative organisms in veterinary ICU patients and hospital environments. Findings from this project provide baseline data on the epidemiology of ESKAPE pathogens in veterinary settings, which can inform infection control policies to aid in patient management and prevent transmission of nosocomial infections associated with these pathogens.
Identifiants
pubmed: 37744932
doi: 10.3389/fmicb.2023.1252216
pmc: PMC10513425
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1252216Informations de copyright
Copyright © 2023 Zendri, Isgren, Devaney, Schmidt, Rankin and Timofte.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Med Microbiol. 2018 Feb;67(2):208-214
pubmed: 29388538
J Glob Antimicrob Resist. 2020 Sep;22:184-189
pubmed: 32061878
Osong Public Health Res Perspect. 2022 Dec;13(6):407-423
pubmed: 36617547
Euro Surveill. 2019 Sep;24(39):
pubmed: 31576806
J Antimicrob Chemother. 2012 Mar;67(3):770-1
pubmed: 22178643
Vet Microbiol. 2017 Feb;200:71-78
pubmed: 27291944
Vet Microbiol. 2018 Mar;216:79-84
pubmed: 29519530
J Antimicrob Chemother. 2014 Oct;69(10):2676-80
pubmed: 24974381
CMAJ. 2009 Feb 17;180(4):408-15
pubmed: 19221354
Microbiol Spectr. 2018 Jul;6(4):
pubmed: 30003866
Antimicrob Agents Chemother. 2019 Mar 27;63(4):
pubmed: 30917985
J Med Microbiol. 2019 Dec;68(12):1723-1731
pubmed: 31746726
Berl Munch Tierarztl Wochenschr. 2014 Nov-Dec;127(11-12):421-7
pubmed: 25872251
Vet Microbiol. 2001 Oct 1;82(4):347-59
pubmed: 11506928
J Small Anim Pract. 2022 Jun;63(6):442-446
pubmed: 35262929
Front Microbiol. 2017 Dec 13;8:2493
pubmed: 29326664
J Am Anim Hosp Assoc. 2021 May 26;57(3):
pubmed: 33770184
PLoS One. 2014 Oct 15;9(10):e110084
pubmed: 25333798
Clin Infect Dis. 2019 May 17;68(11):1823-1830
pubmed: 30239599
Vet Microbiol. 2014 May 14;170(1-2):10-8
pubmed: 24576841
Clin Infect Dis. 2021 Oct 20;73(8):1431-1439
pubmed: 33999991
Vet Microbiol. 2012 Jan 27;154(3-4):298-304
pubmed: 21820821
Can Vet J. 2010 Sep;51(9):963-72
pubmed: 21119862
Equine Vet J. 2012 May;44(3):297-303
pubmed: 21848536
Front Microbiol. 2017 Apr 03;8:543
pubmed: 28421046
Vet J. 2012 Aug;193(2):408-11
pubmed: 22264643
Front Vet Sci. 2020 Jul 10;7:346
pubmed: 32754619
Vet Q. 2015;35(3):123-4
pubmed: 26241405
Vet Rec Open. 2019 Jan 7;6(1):e000307
pubmed: 30687506
mBio. 2014 May 13;5(3):e00985-13
pubmed: 24825010
Clin Microbiol Infect. 2016 Nov;22(11):949.e5-949.e7
pubmed: 27596532
Infect Control Hosp Epidemiol. 2017 Aug;38(8):921-929
pubmed: 28615088
Epidemiol Infect. 2011 Oct;139(10):1511-21
pubmed: 21156096
Curr Opin Infect Dis. 2013 Aug;26(4):338-44
pubmed: 23743816
BMC Infect Dis. 2006 Aug 16;6:130
pubmed: 16914034
J Vet Intern Med. 2008 Jul-Aug;22(4):844-50
pubmed: 18647154
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Vet Clin North Am Small Anim Pract. 2015 Mar;45(2):217-33, v
pubmed: 25559054
Microb Drug Resist. 2016 Oct;22(7):609-615
pubmed: 27314838
J Vet Intern Med. 2006 Jan-Feb;20(1):182-6
pubmed: 16496939
Front Microbiol. 2018 Dec 06;9:2872
pubmed: 30574124
Ir Vet J. 2023 Feb 13;76(1):4
pubmed: 36782258
Appl Environ Microbiol. 2020 Apr 1;86(8):
pubmed: 32033950
Sci Rep. 2017 Jul 14;7(1):5499
pubmed: 28710350
Vet Res Commun. 2023 Jan;47(1):73-86
pubmed: 35449493